These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 2859202)
1. Beta-adrenoceptor subtype of the venous capacity system: characterization by venous occlusion plethysmography. Weber F; Anlauf M Eur J Clin Pharmacol; 1985; 28(2):139-42. PubMed ID: 2859202 [TBL] [Abstract][Full Text] [Related]
2. Subclassification of human beta-adrenergic receptors mediating renin release. Weber F; Brodde OE; Anlauf M; Bock KD Clin Exp Hypertens A; 1983; 5(2):225-38. PubMed ID: 6131758 [TBL] [Abstract][Full Text] [Related]
3. Characterisation of beta-adrenoceptors in equine digital veins: implications of the modes of vasodilatory action of isoxsuprine. Elliott J; Soydan J Equine Vet J Suppl; 1995 Sep; (19):101-7. PubMed ID: 8933076 [TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol. Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869 [TBL] [Abstract][Full Text] [Related]
5. Specialization in beta-1 and beta-2 adrenoceptor distribution in veins of the rabbit face: relationship to myogenic tone and sympathetic nerve innervation. McPherson GA; Bevan JA J Pharmacol Exp Ther; 1987 Jan; 240(1):99-105. PubMed ID: 2879906 [TBL] [Abstract][Full Text] [Related]
6. Celiprolol: agonist and antagonist effects at cardiac beta 1- and vascular beta 2-adrenoceptors determined under in vivo conditions in the rat. Alvarez-Guerra M; Alda O; Garay RP Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):689-98. PubMed ID: 9205952 [TBL] [Abstract][Full Text] [Related]
8. Beta 1- and beta 2-adrenoceptor antagonist activities of ICI-215001, a putative beta 3-adrenoceptor agonist. Tesfamariam B; Allen GT Br J Pharmacol; 1994 May; 112(1):55-8. PubMed ID: 7913381 [TBL] [Abstract][Full Text] [Related]
9. Subtype-selective modulation of human beta 1- and beta 2-adrenoceptor function by beta-adrenoceptor agonists and antagonists. Brodde OE; Daul A; Michel MC Clin Physiol Biochem; 1990; 8 Suppl 2():11-7. PubMed ID: 1982757 [TBL] [Abstract][Full Text] [Related]
10. Mediation of the positive chronotropic effect of CGP 12177 and cyanopindolol in the pithed rat by atypical beta-adrenoceptors, different from beta 3-adrenoceptors. Malinowska B; Schlicker E Br J Pharmacol; 1996 Mar; 117(5):943-9. PubMed ID: 8851515 [TBL] [Abstract][Full Text] [Related]
11. Beta-adrenoceptor antagonists (non-selective as well as beta 1-selective) with partial agonistic activity decrease beta 2-adrenoceptor density in human lymphocytes. Evidence for a beta 2-agonistic component of the partial agonistic activity. Brodde OE; Schemuth R; Brinkmann M; Wang XL; Daul A; Borchard U Naunyn Schmiedebergs Arch Pharmacol; 1986 Jun; 333(2):130-8. PubMed ID: 2875397 [TBL] [Abstract][Full Text] [Related]
12. Intrinsic cardiac neurons involved in cardiac regulation possess alpha 1-, alpha 2-, beta 1- and beta 2-adrenoceptors. Armour JA Can J Cardiol; 1997 Mar; 13(3):277-84. PubMed ID: 9117916 [TBL] [Abstract][Full Text] [Related]
13. Lack of correlation between arterial and venous beta-adrenergic receptor sensitivity. Stein CM; Deegan R; Wood AJ Hypertension; 1997 Jun; 29(6):1273-7. PubMed ID: 9180628 [TBL] [Abstract][Full Text] [Related]
14. Agonist-induced desensitization of beta-adrenoceptor function in humans. Subtype-selective reduction in beta 1- or beta 2-adrenoceptor-mediated physiological effects by xamoterol or procaterol. Brodde OE; Daul A; Michel-Reher M; Boomsma F; Man in 't Veld AJ; Schlieper P; Michel MC Circulation; 1990 Mar; 81(3):914-21. PubMed ID: 1968366 [TBL] [Abstract][Full Text] [Related]
15. The beta-adrenoceptor subtype(s) mediating adrenaline- and dobutamine-induced blood pressure and heart rate changes in healthy volunteers. Daul A; Hermes U; Schäfers RF; Wenzel R; von Birgelen C; Brodde OE Int J Clin Pharmacol Ther; 1995 Mar; 33(3):140-8. PubMed ID: 7599912 [TBL] [Abstract][Full Text] [Related]
18. Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog. Berlan M; Galitzky J; Bousquet-Melou A; Lafontan M; Montastruc JL J Pharmacol Exp Ther; 1994 Mar; 268(3):1444-51. PubMed ID: 7908057 [TBL] [Abstract][Full Text] [Related]
19. Vasodepressor reaction induced by inferior vena cava occlusion and isoproterenol in the rat. Role of beta 1- and beta 2-adrenergic receptors. Waxman MB; Asta JA; Cameron DA Circulation; 1994 May; 89(5):2401-11. PubMed ID: 7910121 [TBL] [Abstract][Full Text] [Related]
20. Terbutaline-induced desensitization of beta 2-adrenoceptor in vivo function in humans: attenuation by ketotifen. Brodde OE; Petrasch S; Bauch HJ; Daul A; Gnadt M; Oefler D; Michel MC J Cardiovasc Pharmacol; 1992 Sep; 20(3):434-9. PubMed ID: 1279289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]